Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06632522 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 9, 2024 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Clinical study of radiotherapy combined with Camrelizumab and Apatinib in the treatment of liver cancer patients with VP4.
Trial Details
NCT Number NCT06632522
Lead Sponsor Beijing Tsinghua Chang Gung Hospital
Conditions
(from sponsor)		 Liver Cancer
Related terms Liver Neoplasms
Enrollment 46 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov